Klementieva Oxana, Sandt Christophe, Martinsson Isak, Kansiz Mustafa, Gouras Gunnar K, Borondics Ferenc
Medical Microspectroscopy Research Group Department of Experimental Medical Science Lund University 22180 Lund Sweden.
Lund Institute for advanced Neutron and X-ray Science (LINXS) 223 70 Lund Sweden.
Adv Sci (Weinh). 2020 Feb 7;7(6):1903004. doi: 10.1002/advs.201903004. eCollection 2020 Mar.
Loss of memory during Alzheimer's disease (AD), a fatal neurodegenerative disorder, is associated with neuronal loss and the aggregation of amyloid proteins into neurotoxic β-sheet enriched structures. However, the mechanism of amyloid protein aggregation is still not well understood due to many challenges when studying the endogenous amyloid structures in neurons or in brain tissue. Available methods either require chemical processing of the sample or may affect the amyloid protein structure itself. Therefore, new approaches, which allow studying molecular structures directly in neurons, are urgently needed. A novel approach is tested, based on label-free optical photothermal infrared super-resolution microspectroscopy, to study AD-related amyloid protein aggregation directly in the neuron at sub-micrometer resolution. Using this approach, amyloid protein aggregates are detected at the subcellular level, along the neurites and strikingly, in dendritic spines, which has not been possible until now. Here, a polymorphic nature of amyloid structures that exist in AD transgenic neurons is reported. Based on the findings of this work, it is suggested that structural polymorphism of amyloid proteins that occur already in neurons may trigger different mechanisms of AD progression.
阿尔茨海默病(AD)是一种致命的神经退行性疾病,其记忆丧失与神经元丢失以及淀粉样蛋白聚集成富含神经毒性β折叠的结构有关。然而,由于在研究神经元或脑组织中的内源性淀粉样蛋白结构时面临诸多挑战,淀粉样蛋白聚集的机制仍未得到很好的理解。现有的方法要么需要对样品进行化学处理,要么可能会影响淀粉样蛋白结构本身。因此,迫切需要能够直接在神经元中研究分子结构的新方法。一种基于无标记光学光热红外超分辨率显微光谱技术的新方法经过测试,可在亚微米分辨率下直接在神经元中研究与AD相关的淀粉样蛋白聚集。使用这种方法,在亚细胞水平、沿神经突以及令人惊讶的是在树突棘中检测到了淀粉样蛋白聚集体,而这在以前是不可能做到的。在此,报道了AD转基因神经元中存在的淀粉样蛋白结构的多态性。基于这项工作的发现,有人提出,在神经元中就已出现的淀粉样蛋白的结构多态性可能会引发AD进展的不同机制。